Recently, OpenAI's chatbot ChatGPT has topped global rankings, reaching over 100 million monthly active users in just one month, and its popularity continues to soar. With a vast database of linguistic data, ChatGPT can effortlessly perform tasks such as market analysis, thesis writing, poetry composition, music composition, painting, and copywriting. Its language interaction mode, which closely resembles human communication, is particularly impressive.

In the past, scholars and poets would agonize over the beauty of diction and rhyme, deliberating on word choices and sentence structures, sometimes insisting that "no startling phrase means death." Today, people need only type a few "keywords" on a screen, and ChatGPT can create a magnificent piece of work with ease. ChatGPT is akin to a versatile polymath warrior, embodying the wisdom of human technological civilization, effortlessly handling tasks like coding, copywriting, translation, and spreadsheet creation.

ChatGPT utilizes a large language model, having been trained on extensive text data, enabling it to respond to a wide array of questions with human-like answers. Its communication style sounds and appears incredibly natural. Additionally, it can access databases, mimic human writing processes, and generate content and manuscripts by using algorithms combined with given parameters such as theme, location, and time.

In the field of protein engineering, synthetic biology AI platforms play a role similar to that of ChatGPT, integrating artificial intelligence technology with machine learning and deep learning to design enzyme components for high-throughput screening. By mimicking natural protein templates within computer systems and utilizing given parameters, these platforms employ algorithms to synthesize new proteins, significantly shortening the trial-and-error process in laboratories and accelerating the development cycle of new proteins.

As a well-known producer of HMOs in China, Henglu Biotech established an artificial intelligence technology team as early as 2021. They built the Henglu Intelligent AI Computing Cloud Platform (HLBrain), a synthetic biology AI research and development innovation platform, and continually enriched a protein database. By integrating artificial intelligence technology, high-throughput screening, and expression, they combine next-generation fermentation engineering technology with life sciences, information technology, and artificial intelligence disciplines, speeding up the industrialization and research and development of functional active substances.

“The Henglu Intelligent AI Computing Cloud Platform has designed tens of thousands of new proteins, which are now used in the synthesis processes of new enzyme preparations, including human milk oligosaccharides,” said Professor Fang Xu, founder and chief scientist of Henglu Biotech. He stated that the AI computing cloud platform can freely generate protein structures that resemble nature or have specific functions from scratch. These synthetic proteins not only share similarities with natural protein structures, but some innovative proteins also exhibit biological activities that natural proteins do not have, providing broader research space for designing new substances and products not found in nature.

Currently, Henglu Biotech has advanced various cell factories and enzyme catalysis into the stage of industrial application. With the support of the "artificial intelligence + synthetic biology" research and development platform, as well as the "yeast cell factory + enzyme catalysis" approach, the pace of synthetic biology research and development has been significantly accelerated. Previously, tasks that took years in the laboratory can now be completed in just a few weeks using the HLBrain computing cloud platform. The "IT + BT" model enhances research efficiency, expands research possibilities, and reduces research costs, providing a broad release space for the revolutionary innovation potential of synthetic biology, offering comprehensive support for the development and industrialization of synthetic biology technology.